132 related articles for article (PubMed ID: 11135464)
41. Qualifiers of atypical squamous cells of undetermined significance help in patient management.
Collins LC; Wang HH; Abu-Jawdeh GM
Mod Pathol; 1996 Jun; 9(6):677-81. PubMed ID: 8782207
[TBL] [Abstract][Full Text] [Related]
42. Management of patients with atypical squamous cells of undetermined significance (ASCUS) on Papanicolaou smears.
Terry RR
J Am Osteopath Assoc; 1996 Aug; 96(8):465-8. PubMed ID: 8810157
[TBL] [Abstract][Full Text] [Related]
43. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
44. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
45. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
[TBL] [Abstract][Full Text] [Related]
46. Improved abnormal Pap smear triage using cervical cancer biomarkers.
Killeen JL; Dye T; Grace C; Hiraoka M
J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145
[TBL] [Abstract][Full Text] [Related]
47. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
[TBL] [Abstract][Full Text] [Related]
48. The use of endocervical curettage in women with low-grade squamous intraepithelial lesions or atypical squamous cells of unknown significance on Pap smear.
Miranda AD; Rodríguez R; Novoa DM; Rojas A; Pachón A; DiazGranados CA
J Low Genit Tract Dis; 2006 Jul; 10(3):146-50. PubMed ID: 16829753
[TBL] [Abstract][Full Text] [Related]
49. Cell block findings from residual PreservCyt samples in unsatisfactory ThinPrep Paps: no additional benefit.
Kabbani W; Raisanen J; Thomas S; Saboorian MH; Ashfaq R
Diagn Cytopathol; 2002 Oct; 27(4):238-43. PubMed ID: 12357503
[TBL] [Abstract][Full Text] [Related]
50. The clinical significance of atypical squamous cells of undetermined significance: a laboratory audit of cervical reporting.
Roche DH; Spicer N
N Z Med J; 2001 Feb; 114(1126):64-6. PubMed ID: 11280428
[TBL] [Abstract][Full Text] [Related]
51. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa.
Adam Y; McIntyre JA; De Bruyn G
S Afr Med J; 2012 Nov; 103(1):34-9. PubMed ID: 23237122
[TBL] [Abstract][Full Text] [Related]
52. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
53. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
[TBL] [Abstract][Full Text] [Related]
54. ASCUS on cervical cytologic smears. Clinical significance.
Yang M; Zachariah S
J Reprod Med; 1997 Jun; 42(6):329-31. PubMed ID: 9219118
[TBL] [Abstract][Full Text] [Related]
55. Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS Pap smear.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
Acta Cytol; 2000; 44(4):576-86. PubMed ID: 10934951
[TBL] [Abstract][Full Text] [Related]
56. [Association between the cervico-vaginal inflammatory cytology and the intraepithelial cervical lesion in patients from a sexual and reproductive health clinic in Bogotá, Colombia, 1999-2003].
Duarte HG; Romero JA; Schmalbach JE
Rev Salud Publica (Bogota); 2004; 6(3):253-69. PubMed ID: 15656066
[TBL] [Abstract][Full Text] [Related]
57. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
[TBL] [Abstract][Full Text] [Related]
58. Rapid prescreening as a quality assurance measure in cervical cytology.
Repse-Fokter A; Caks-Golec T
Acta Cytol; 2009; 53(3):268-70. PubMed ID: 19534265
[TBL] [Abstract][Full Text] [Related]
59. Loss to follow-up of cervical smears without endocervical columnar cells is not disturbing.
Tacken MA; Braspenning JC; Mulder J; Hermens RP; Nelen WL; de Bakker DH; Grol RP
Eur J Gynaecol Oncol; 2006; 27(1):42-6. PubMed ID: 16550967
[TBL] [Abstract][Full Text] [Related]
60. Cytomorphologic findings of cervical Pap smears from female-to-male transgender patients on testosterone therapy.
Williams MPA; Kukkar V; Stemmer MN; Khurana KK
Cancer Cytopathol; 2020 Jul; 128(7):491-498. PubMed ID: 32125771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
